V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230002336 | 230004782 | null | null | null | null | 2016-10-09 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100995690 |
| 230002339 | 230004785 | 1.55 | 79.6 | Neo-adjuvant (N) | 2019-03-24 | 2019-11-08 | null | N | null | TEMOZOLOMIDE | 101791586 |
| 230002340 | 230004786 | 1.67 | 66.9 | null | 2021-09-19 | 2021-09-22 | null | 02 | null | CISPLATIN | 101496886 |
| 230002341 | 230004787 | 1.64 | 128 | null | null | 2019-02-01 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101105721 |
| 230002342 | 230004788 | 1.65 | 60.5 | null | 2021-08-04 | 2021-10-15 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100749516 |
| 230002343 | 230004789 | null | null | Adjuvant (A) | null | 2019-11-15 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100055197 |
| 230002344 | 230004790 | null | null | null | null | 2018-12-11 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100985732 |
| 230002347 | 230004793 | null | null | null | null | 2021-11-16 | Cisplatin | null | null | CARBOPLATIN | 101865082 |
| 230002348 | 230004794 | 1.62 | 79.2 | Curative (C) | null | 2019-06-19 | Bevacizumab 7.5mg/kg | 02 | N | BEVACIZUMAB | 100405225 |
| 230002349 | 230004795 | 1.61 | 95.2 | null | 2016-04-22 | 2017-03-19 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100379957 |
| 230002350 | 230004796 | null | null | Palliative (P) | 2022-01-14 | 2022-03-28 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100500638 |
| 230002351 | 230004797 | 1.62 | 92 | null | null | 2019-02-20 | null | null | null | IPILIMUMAB + NIVOLUMAB | 100331322 |
| 230002352 | 230004798 | 1.62 | 72 | Palliative (P) | 2017-11-19 | 2017-12-03 | Bevacizumab | 02 | null | BEVACIZUMAB | 100003768 |
| 230002355 | 230004801 | 1.5 | 98.3 | null | null | 2019-05-30 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100367867 |
| 230002356 | 230004802 | 1.58 | 72.7 | Palliative (P) | null | 2018-10-04 | Bevacizumab | 02 | N | BEVACIZUMAB | 101583335 |
| 230002357 | 230004803 | 1.6 | 71.4 | null | null | 2019-08-25 | null | null | null | IPILIMUMAB + NIVOLUMAB | 100007555 |
| 230002359 | 230004805 | 1.52 | 43.9 | null | null | 2019-10-04 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101386716 |
| 230002360 | 230004806 | 1.73 | 0 | null | 2017-06-22 | 2017-06-22 | null | null | null | ETOPOSIDE | 101558241 |
| 230002361 | 230004807 | 1.67 | 78.3 | null | 2019-12-07 | 2019-12-14 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100917838 |
| 230002364 | 230004810 | 1.57 | 88 | null | 2017-10-16 | 2017-10-23 | CAP | 02 | null | DOXORUBICIN | 100896076 |
| 230002365 | 230004811 | 1.66 | 49.5 | null | 2021-04-12 | 2021-04-26 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 100255754 |
| 230002366 | 230004812 | 1.55 | null | null | null | 2017-10-01 | null | null | null | IPILIMUMAB + NIVOLUMAB | 101050517 |
| 230002368 | 230004814 | 1.56 | 55.4 | null | 2019-09-01 | 2019-09-01 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 100273349 |
| 230002371 | 230004817 | null | null | Neo-adjuvant (N) | 2018-08-27 | 2020-03-12 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101101881 |
| 230002372 | 230004818 | 1.6 | 39 | null | 2016-11-08 | 2016-11-16 | null | null | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100562230 |
| 230002375 | 230004821 | 1.5 | 68.8 | null | 2020-10-03 | 2020-10-14 | Liposomal Doxorubicin 40mg/m2 | 02 | null | LIPOSOMAL DOXORUBICIN | 101492195 |
| 230002376 | 230004822 | 1.55 | 93.5 | Palliative (P) | 2022-05-10 | 2022-05-17 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100845043 |
| 230002377 | 230004823 | 1.61 | 62.7 | null | null | 2019-10-30 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101484074 |
| 230002378 | 230004824 | null | null | null | null | 2019-02-27 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100264048 |
| 230002379 | 230004825 | 1.7 | 48.4 | null | 2022-05-03 | 2022-05-03 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100149124 |
| 230002380 | 230004826 | 1.48 | 62 | Neo-adjuvant (N) | 2021-07-13 | 2021-07-26 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101857521 |
| 230002382 | 230004828 | 1.61 | 75 | 03 | 2020-01-25 | 2020-02-01 | Bevacizumab | 02 | N | BEVACIZUMAB | 101385347 |
| 230002383 | 230004829 | null | null | Neo-adjuvant (N) | 2020-12-10 | 2021-01-21 | null | 02 | N | NIVOLUMAB | 100262604 |
| 230002384 | 230004830 | 1.68 | 62.2 | null | null | 2019-01-26 | null | null | null | OLAPARIB | 100492678 |
| 230002386 | 230004832 | 1.68 | 92.6 | null | 2021-08-28 | 2021-10-02 | null | null | null | PACLITAXEL | 101090814 |
| 230002387 | 230004833 | 1.59 | 83.9 | null | 2016-03-21 | 2016-09-23 | null | null | null | OLAPARIB | 101509405 |
| 230002389 | 230004835 | 1.58 | 58.2 | 03 | 2017-02-13 | 2017-03-21 | null | null | N | NIRAPARIB | 101327063 |
| 230002390 | 230004836 | null | null | null | null | 2020-02-01 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100193772 |
| 230002393 | 230004839 | null | null | null | 2019-12-23 | 2019-12-30 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 100599014 |
| 230002394 | 230004840 | 1.56 | 59.2 | null | null | 2018-09-19 | ETOPOSIDE | null | null | CARBOPLATIN | 100074082 |
| 230002397 | 230004843 | 1.63 | 65.2 | null | 2016-10-17 | 2017-05-21 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100077095 |
| 230002401 | 230004847 | 1.61 | 104.9 | Curative (C) | 2020-05-09 | 2020-05-21 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100698941 |
| 230002402 | 230004848 | null | null | Palliative (P) | 2019-05-08 | 2020-01-24 | null | null | N | TRASTUZUMAB EMTANSINE | 100543219 |
| 230002403 | 230004849 | 1.53 | 67.7 | Adjuvant (A) | null | 2019-05-27 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100891731 |
| 230002412 | 230004857 | 1.76 | 63.2 | null | null | 2016-08-29 | PACLITAXEL | 02 | null | PACLITAXEL | 101528187 |
| 230002415 | 230004859 | 1.58 | 71.3 | Curative (C) | 2019-05-19 | 2019-06-06 | Liposomal Doxorubicin (Caelyx) | 02 | N | LIPOSOMAL DOXORUBICIN | 100742033 |
| 230002418 | 230004862 | 1.59 | 81.6 | null | 2018-11-06 | 2019-08-18 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 101513177 |
| 230002424 | 230004868 | 1.52 | 76.1 | null | null | 2020-01-04 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100346889 |
| 230002425 | 230004869 | 1.62 | 94.95 | Palliative (P) | 2020-04-11 | 2020-04-22 | PEMBROLIZUMAB | 02 | N | CYCLOPHOSPHAMIDE | 101715087 |
| 230002426 | 230004870 | null | null | null | 2019-07-04 | 2019-07-17 | null | null | null | PEMBROLIZUMAB | 100842547 |